FDA’s device center announced on Wednesday (March 13) that it will launch its long-planned internal reorganization aimed at addressing the total life cycle of products on March 18 and, should all go as planned, complete the overhaul by Sept. 30, 2019. Though the announcement did not reveal any new details on how that transition will unfold, it marks an official start to an initiative the agency has heralded since it was first announced in early 2018. The goal of the...